Comparative Pharmacology
Head-to-head clinical analysis: INTRALIPID 10 versus INTRALIPID 20.
Head-to-head clinical analysis: INTRALIPID 10 versus INTRALIPID 20.
INTRALIPID 10% vs INTRALIPID 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intralipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of energy. It acts as a carrier for fat-soluble vitamins and prevents essential fatty acid deficiency. The mechanism involves direct utilization of triglycerides for energy after hydrolysis by lipoprotein lipase.
Intralipid 20% is a fat emulsion providing essential fatty acids and triglycerides. It serves as a source of calories and essential fatty acids. In parenteral nutrition, it prevents and treats essential fatty acid deficiency. In lipid rescue therapy for local anesthetic toxicity, it acts as a 'lipid sink' to sequester lipophilic drugs, and may also enhance mitochondrial fatty acid oxidation and improve cardiac contractility.
Intravenous infusion. Adult: 500 mL of 10% emulsion (50 g fat) over 4-6 hours, up to 2.5 g fat/kg/day. Maximum infusion rate: 0.1 g fat/kg/hour.
Intravenous infusion at a rate of 0.1 g fat/kg/hour, increasing to 0.5 g fat/kg/hour if tolerated. Maximum daily dose: 2.5 g fat/kg (50 mL/kg/day of 20% emulsion).
None Documented
None Documented
The terminal elimination half-life of Intralipid triglycerides is approximately 30-60 minutes in adults with normal lipid metabolism. In neonates and patients with impaired clearance, half-life may be prolonged to 2-4 hours. Clinical context: half-life increases with infusion rate; at steady state, clearance is rapid due to extrahepatic lipolysis.
Terminal elimination half-life of lipid particles: approximately 30 minutes for chylomicron-like particles; triglycerides half-life ~15-30 minutes. Clinical context: rapid clearance by lipoprotein lipase.
Intralipid 10% (IV fat emulsion) is metabolized like endogenous chylomicrons; elimination is not via renal or biliary routes. Triglycerides are hydrolyzed by lipoprotein lipase, and the resulting free fatty acids are taken up by tissues. Less than 0.5% is excreted unchanged in urine. Biliary excretion of metabolites is negligible.
Renal: negligible. Biliary/fecal: >90% as component of lipid metabolism, excretion via bile and fecal elimination of lipid particles.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion